Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis

Author： Mukhopadhyay S. Sen P. Bhattacharyya S. Majumdar S. Roy S.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.3, 1999-02, pp. : 291-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

By Paraguai de Souza E. Bernardo R.R. Palatnik M. Palatnik de Sousa C.B.

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3104-3115

Elsevier

Access to resources Recommend Favorite

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani

By Santos W.R. Paraguai de Souza E. Palatnik M. Palatnik de Sousa C.B.

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2554-2561

Elsevier

Access to resources Recommend Favorite

ISCOMs vaccine against experimental leishmaniasis

By Papadopoulou G. Karagouni E. Dotsika E.

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 885-892

Elsevier

Access to resources Recommend Favorite

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

By Santos W.R. de Lima V.M.F. de Souza E.P. Bernardo R.R. Palatnik M. de Sousa C.B.P.

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 30-43

Elsevier

Access to resources Recommend Favorite

The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis

By Solioz N. Blum-Tirouvanziam U. Jacquet R. Rafati S. Corradin G. Mauel J. Fasel N.

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 850-859

Elsevier

Access to resources Recommend Favorite